financetom
Business
financetom
/
Business
/
Third Coast Bancshares Q2 EPS rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Third Coast Bancshares Q2 EPS rises
Jul 23, 2025 2:18 PM

Overview

* Third Coast Bancshares ( TCBX ) fiscal Q2 EPS hits record-high $0.96, net income $16.7 mln

* Net interest margin improves to 4.22% in fiscal Q2, driven by loan yields

* Co completed $100 millionand$150 million commercial real estate loan securitizations

Result Drivers

* NET INTEREST INCOME - Increased 15.4% from Q1 2025 due to higher loan yields and successful loan securitizations

* EFFICIENCY IMPROVEMENT - Efficiency ratio improved to 55.45% in Q2 2025, reflecting better operational discipline

* LOAN GROWTH - Gross loans grew to $4.08 bln, driven by commercial and industrial loans

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 EPS $0.96

Q2 Net $16.75

Income mln

Q2 Net $49.37

Interest mln

Income

Q2 Loan $2.13

Loss mln

Provisio

n

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the banks peer group is "buy"

* Wall Street's median 12-month price target for Third Coast Bancshares Inc ( TCBX ) is $38.00, about 5.8% above its July 22 closing price of $35.80

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioAge Labs Shares Surge on Nasdaq Debut
BioAge Labs Shares Surge on Nasdaq Debut
Sep 26, 2024
12:40 PM EDT, 09/26/2024 (MT Newswires) -- BioAge Labs (BIOA) shares were up almost 28% in recent trading Thursday after debuting on Nasdaq, higher than the initial public offering price of $18 per share. The stock is trading under the ticker symbol BIOA. The company is offering 11 million shares in the IPO for gross proceeds of $198 million and...
Fulcrum Therapeutics to Cut Jobs, Reprioritize R&D Activities
Fulcrum Therapeutics to Cut Jobs, Reprioritize R&D Activities
Sep 26, 2024
05:27 PM EDT, 09/24/2024 (MT Newswires) -- Fulcrum Therapeutics ( FULC ) said Tuesday its board has approved a restructuring plan that will trim its workforce to 51 full-time employees from 80. The company said its goal is to reprioritize research and development activities to focus on advancing pociredir for the treatment of sickle cell disease, novel therapeutic agents for...
BRIEF-Blue Hill Advisors Raises Cash Offer For Territorial Bancorp
BRIEF-Blue Hill Advisors Raises Cash Offer For Territorial Bancorp
Sep 26, 2024
Sept 26 (Reuters) - Blue Hill Advisors: * BLUE HILL ADVISORS ANNOUNCES INCREASED CASH OFFER FOR TERRITORIAL BANCORP * BLUE HILL ADVISORS: RAISES CASH OFFER FROM $12.00 TO $12.50 Source text for Eikon: Further company coverage: ...
CACI International Awarded $314 Million Task Order
CACI International Awarded $314 Million Task Order
Sep 26, 2024
05:27 PM EDT, 09/24/2024 (MT Newswires) -- CACI International ( CACI ) said Tuesday it has been awarded a five-year task order worth up to $314 million to provide engineering services and technology to the US Navy's Naval Undersea Warfare Center. CACI ( CACI ) said it will develop, deliver, and train sailors in the areas of integration support, logistics,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved